FCM
BIIB icon

Flinton Capital Management’s Biogen BIIB Stock Holding History

Flinton Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$8.26M Sell
35,488
-6,064
-15% -$1.41M 0.26% 76
2019
Q2 		$9.72M Sell
41,552
-12,672
-23% -$2.93M 0.31% 66
2019
Q1 		$12.8M Buy
54,224
+12,064
+29% +$3.8M 0.42% 46
2018
Q4 		$12.7M Sell
42,160
-3,024
-7% -$965K 0.48% 45
2018
Q3 		$16M Sell
45,184
-2,880
-6% -$992K 0.49% 43
2018
Q2 		$13.9M Buy
48,064
+5,888
+14% +$1.66M 0.45% 51
2018
Q1 		$11.5M Buy
42,176
+20,352
+93% +$6.32M 0.39% 60
2017
Q4 		$6.95M Buy
21,824
+8,160
+60% +$2.62M 0.24% 95
2017
Q3 		$4.28M Buy
13,664
+2,672
+24% +$791K 0.15% 133
2017
Q2 		$2.98M Buy
10,992
+5,424
+97% +$1.43M 0.11% 157
2017
Q1 		$1.52M Buy
5,568
+3,776
+211% +$1.07M 0.06% 214
2016
Q4 		$508K Buy
+1,792
New +$531K 0.02% 326

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Flinton Capital Management's BIIB Position: Q3 2019 in Review

Flinton Capital Management reduced its Biogen (BIIB) stake by 15% in Q3 2019, selling an estimated $1.41M and leaving 35,488 shares worth $8.26M. The position accounts for 0.26% of the portfolio, ranked #76.

Flinton Capital Management first reported a position in BIIB in Q4 2016 and has held it in 12 quarters since. The position peaked at $16M in Q3 2018. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Flinton Capital Management held 35,488 shares of Biogen worth $8.26M as of Q3 2019.
  • Flinton Capital Management sold 6,064 Biogen shares in Q3 2019, an estimated $1.41M.
  • Biogen made up 0.26% of Flinton Capital Management's portfolio in Q3 2019, its #76 holding.
  • Flinton Capital Management first reported a position in Biogen in Q4 2016 and has held it in 12 quarters since.
  • Flinton Capital Management's Biogen position peaked at $16M in Q3 2018.
  • 988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.